HSBC Holdings’s Kezar Life Sciences KZR Stock Holding History

HSBC Holdings’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,596	Closed	-$52K	–	3125
2019 Q3	$52K	Buy	+1,596	New	+$77.1K	﹤0.01%	3015

Other funds holding KZR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSBC Holdings's KZR Position: Q4 2019 in Review

HSBC Holdings sold out of Kezar Life Sciences (KZR) in Q4 2019, closing a stake of 1,596 shares — an estimated $52K sold.

HSBC Holdings first reported a position in KZR in Q3 2019 and held it in 1 quarter. The position peaked at $52K in Q3 2019. 55 funds tracked by Wall St. Rank hold KZR as of Q4 2019.

HSBC Holdings reported no remaining Kezar Life Sciences position as of Q4 2019 after selling out during the quarter.
HSBC Holdings sold 1,596 Kezar Life Sciences shares in Q4 2019, an estimated $52K.
HSBC Holdings first reported a position in Kezar Life Sciences in Q3 2019 and held it in 1 quarter.
HSBC Holdings's Kezar Life Sciences position peaked at $52K in Q3 2019.
55 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2019.

Based on HSBC Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.